Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Alan Balch
Klinik Araştırmalara Katılım Önündeki Engeller Neler?
Klinik araştırmalara gönüllü katılımı sağlamak, hastaların doğru çalışmalarla eşleştirilmesi ve sürecin yönetilmesi oldukça karmaşık ve zorlu bir süreç. Ancak istatistikler, hastaların büyük çoğunluğunun bu sürece dahil olmak istediğini, buna karşın çoğuna hiç ulaşılmadığını gösteriyor. Son dönemde bu tabloyu değiştirmek için hem yasal hem de kurumsal düzeyde önemli adımlar atılıyor. KLİNİK ARAŞTIRMALARA KATILIM NEDEN DÜŞÜK?
Your Insider Playbook to Driving Efficiency in Hub Operations
Empower your patient access team to navigate the IRA, MP3 redesign, Medicaid changes, DOJ enforcement trends and more. Learn how to build compliant, sustainable patient support programs that protect access and affordability.
Uniting for Patients: Helping More Americans Navigate, Access and Afford Health Care
Patients nationwide are facing rising barriers to care, growing affordability challenges and a weakened health care safety net. The need for support has never been greater, which is why on March 3, 2026, Patient Advocate Foundation and the PAN Foundation announced a strategic merger, creating the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access and afford their care.
Pharma Pulse: US Exits the World Health Organization; Hospitals Overwhelmed by Historic Flu Crisis
Commentary|Podcasts|January 23, 2026 In today’s Pharma Pulse, the United States finalizes its departure from global health oversight, while domestic providers face a record-breaking surge in respiratory hospitalizations. Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and let’s get into today’s headlines.
FDA Reviews ImportShield Program as Processing Gains Boost Import Oversight and Supply Chain Protection
The FDA will be reviewing the effectiveness of its FDA ImportShield Program (FISP)—an initiative that was unveiled in August 2025—which is intended to streamline how the FDA reviews imported products.1 Since that time, FISP has reportedly boosted processing speed by 66% and monthly volume capacity by 33%. Staff hours have also decreased by 20%, with monthly time savings of 3,388 hours.
The Future of Drug Safety
This video was created based on an article written by Updesh Dosanjh: The Next Era of Drug Safety is in Intelligent Action When it comes to medicine, nothing is more important than safety. But what happens when the clues you need to ensure that safety are buried in a mountain of data? Well, today, we're diving into how artificial intelligence is completely changing the game for drug safety, turning what used to be data overload into a real-life saving advantage. I mean, think about it.
Pharma Pulse: Federal Funding Averts Shutdown and Pfizer’s Adjuvant Play
Commentary|Podcasts|January 22, 2026 In today’s Pharma Pulse, Congress races to secure funding, while Novavax nets a half-billion-dollar validation of its non-aluminum vaccine technology. Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and let’s get into today’s headlines.
Hardis Supply Chain Expands into North America as Demand for Cloud and Automation Accelerates
Hardis Supply Chain, a France-based provider of supply chain software and technology solutions, is expanding its services into North America. According to a company press release,1 this decision follows a demand in the US market for cloud-based and automated logistics solutions.
Complexities Behind Choosing and Using Health Insurance
According to Alan Balch, PhD, CEO of the Patient Advocate Foundation and the National Patient Advocate Foundation, rising employer-sponsored insurance premiums—outpacing both inflation and wage growth—are creating severe financial pressure for low- and middle-income families. He describes a “perfect storm” in which healthcare costs are increasing alongside everyday expenses such as housing, food, and utilities, while household incomes fail to keep pace.
Pharma Pulse: Industry Backlash, GSK’s $2.2B Immunology Bet, and the Future of Wearables
Commentary|Podcasts|January 21, 2026 In today’s Pharma Pulse, over 200 health groups denounce childhood vaccine schedule cuts, GSK acquires RAPT Therapeutics, and BD partners with ten23 health to scale large-volume injectors. Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and let’s get into today’s headlines.
ten23 Health and BD Team Up to Scale Wearable Injectors for High-Volume Subcutaneous Drug Delivery
ten23 health, a Swiss contract development and manufacturing organization (CDMO), is collaborating with BD (Becton, Dickinson and Company), to assist with the commercialization of its wearable injectable, BD Libertas.1 The partnership is expected to provide biopharma companies with a product that offers the subcutaneous delivery of large-volume drugs, accelerating development, while lowering risk in complex injectable programs in the process.
Strengthening the Safety Net for Chronically Ill, Lower-Income Patients
According to Alan Balch, PhD, CEO of the Patient Advocate Foundation and the National Patient Advocate Foundation, rising employer-sponsored insurance premiums—outpacing both inflation and wage growth—are creating severe financial pressure for low- and middle-income families. He describes a “perfect storm” in which healthcare costs are increasing alongside everyday expenses such as housing, food, and utilities, while household incomes fail to keep pace.
Pharma Pulse: Global AI Alignment, the TrumpRx Pivot, and Nano-Delivery GLP-1s
Commentary|Podcasts|January 20, 2026 In today’s Pharma Pulse, the FDA and EMA synchronize on AI standards, a potential divide in pricing strategy occurs, and BoomRx launches a needle-free nanoemulsion for weight loss. Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and let’s get into today’s headlines.
BoomRx Expands Access to Oral Semaglutide and Tirzepatide Using Nanoemulsion Delivery
BoomRx, a pharmaceutical technology platform that simplifies prescription sourcing and fulfillment by providing healthcare professionals (HCPs) with access to weight management therapies, has now made both oral semaglutide and tirzepatide options available via its platform.1 The options will be using advanced nanoemulsion delivery, for use by medical clinics, telemedicine providers, wellness facilities, and med spas.
The Hidden Economics of Health Insurance Affordability
According to Alan Balch, PhD, CEO of the Patient Advocate Foundation and the National Patient Advocate Foundation, rising employer-sponsored insurance premiums—outpacing both inflation and wage growth—are creating severe financial pressure for low- and middle-income families. He describes a “perfect storm” in which healthcare costs are increasing alongside everyday expenses such as housing, food, and utilities, while household incomes fail to keep pace.
Pharma Pulse: Novartis Warns of Trade Fragmentation; Hospital M&A Hits Record Low; Copay Shock Warning
Commentary|Podcasts|January 19, 2026 In today’s Pharma Pulse, Novartis calls for a shift from "cost-containment" to structural reform, hospital mergers hit their lowest point in 15 years, and new data warns of "cost shocks" driven by copay accumulators. Your browser does not support the audio element. Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation.
Dawsongroup tcs USA Launches in the States
There is a new cold chain company in town. Dawsongroup tcs USA has officially launched in the United States, and in the process, is introducing its modular cold chain system—known as the Superbox—to the American market.1 The new South Carolina-based company is financially supported by Dawsongroup tcs, a temperature-controlled solutions powerhouse in its own right, with more than 30 years of experience in Europe and a lineup of over 30,000 assets.
Affordability Strain Is Moving Up the Income Ladder
According to Alan Balch, PhD, CEO of the Patient Advocate Foundation and the National Patient Advocate Foundation, rising employer-sponsored insurance premiums—outpacing both inflation and wage growth—are creating severe financial pressure for low- and middle-income families. He describes a “perfect storm” in which healthcare costs are increasing alongside everyday expenses such as housing, food, and utilities, while household incomes fail to keep pace.
Pharma Pulse: Trump’s New Healthcare Roadmap, FDA Vaccine Warnings, and BPD to Lead The Agency Network
Commentary|Podcasts|January 16, 2026 In today’s Pharma Pulse, President Trump unveils a patient payment plan, the FDA flags a rare seizure risk for several leading flu vaccines, and MJH Life Sciences expands its data-driven reach. Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and let’s get into today’s headlines.
Evaluate’s 2026 Pharma Forecast Signals Cautious Recovery, Rising M&A, and GLP-1 Market Shifts
Evaluate, known for providing market insights for the pharma sector, has recently unveiled its 2026 Preview report,1 which offers a 2026 market forecast. According to the report, biopharma has reclaimed momentum after a prolonged period of tight financing and limited investor support. However, it’s predicted that the industry will remain in a cautious recovery phase in 2026.
Premium Inflation Is Reshaping Patient Access and Adherence
Commentary|Videos|January 15, 2026 Author(s)Nicholas Saraceno, Senior Editor, Alan Balch, PhD In the first part of his Pharma Commerce video interview, Alan Balch, PhD, CEO of the Patient Advocate Foundation and the National Patient Advocate Foundation, how mounting financial pressure is forcing patients to ration care, undermining treatment adherence and accelerating downstream clinical and economic risk.
18th Annual Outsourcing in Clinical Trials West Coast 2026
Back Rachel Yan Former Director, Clinical Operations, Allay Therapeutics Experienced analytical professional with a versatile background in the biotechnology industry and clinical research site. Skilled in project management, quality compliance, protocol development, site management, clinical pharmacology and clinical trials in autoimmune, allergy, cardiovascular, nephrology, neuromuscular, pain and pediatrics.
Covalently linked thieno[2,3-b]thiophene-fullerene dimers: synthesis and physical characterization
Covalently linked thieno[2,3-b]thiophene-fullerene dimers: synthesis and physical characterization† Thienothiophene (TT) has received great attention in the fields of electronics and optoelectronics. Here we report a synthesis and characterization of fullerene-donor-fullerene triads linked to thieno[2,3-b]thiophene as a donor.
Open-Cage Fullerenes as Ligands for Metals
Open-Cage Fullerenes as Ligands for Metals The remarkable structures of open-cage fullerenes with functionalization on the outer surface and an accessible inner void make them interesting ligands for reactions with metal complexes. The behavior of open-cage fullerenes in reactions with various metal complexes are examined and compared to corresponding reactions with intact fullerenes. Structural results from X-ray diffraction are emphasized.
Financial Navigation in Cancer Care Delivery: State of the Evidence, Opportunities for Research, and Future Directions
Background Financial toxicity (FT) describes the significant economic burden imposed by cancer treatment on American households.1 In recent years, the incidence and severity of FT have regrettably escalated because of the high cost structure (direct and indirect) associated with cancer diagnosis, treatment, and survivorship. This reality has heightened attention, across the broad health care stakeholder community, to finding solutions to FT at the policy, payer, and health system levels.
Health Care Value Through The Lens Of Patients’ Well-Being
This article is part of the Health Affairs Forefront short series, “Value Assessment: Where Do We Go Post-COVID?” The series explores what we have learned about value assessment and related issues during the coronavirus pandemic, how we might think about value in health care going forward, and how these ideas might translate into policy.
Health Care Value Through The Lens Of Patients’ Well-Being
Editor’s Note This article is part of the Health Affairs Forefront short series, “Value Assessment: Where Do We Go Post-COVID?” The series explores what we have learned about value assessment and related issues during the coronavirus pandemic, how we might think about value in health care going forward, and how these ideas might translate into policy.
Introduction of a (Ph3P)2Pt Group into the Rim of an Open-cage Fullerene by Breaking a Carbon-Carbon Bond
Introduction of a (Ph3P)2Pt Group into the Rim of an Open-cage Fullerene by Breaking a Carbon-Carbon Bond Treatment of an open-cage fullerene, designated as MMK-9, with (Ph3P)4Pt in toluene solution at room temperature allows a Pt(PPh3)2 unit to be incorporated into the rim of the cage so that it becomes an integral part of the carbon cage skeleton.
A non-luminescent polymorph of [(cyclohexyl isocyanide)2Au]PF6 that becomes luminescent upon grinding or exposure to dichloromethane vapor
A non-luminescent polymorph of [(cyclohexyl isocyanide)2Au]PF6 that becomes luminescent upon grinding or exposure to dichloromethane vapor† The discovery of a third, non-luminescent crystalline polymorph of [(C6H11NC)2Au]PF6 is reported. Remarkably, crystals of this polymorph are sensitive to mechanical pressure or to exposure to dichloromethane vapor.
A Non-Luminescent Polymorph of [(Cyclohexyl Isocyanide)2Au]PF6 that Becomes Luminescent Upon Grinding or Exposure to Dichloromethane Vapor
A Non-Luminescent Polymorph of [(Cyclohexyl Isocyanide)2Au]PF6 that Becomes Luminescent Upon Grinding or Exposure to Dichloromethane Vapor The discovery of a third, non-luminescent crystalline polymorph of [(C6H11NC)2Au]PF6 is reported. Remarkably, crystals of this polymorph are sensitive to mechanical pressure or to exposure to dichloromethane vapor.
Role of Anions and Mixtures of Anions on the Thermochromism, Vapochromism, and Polymorph Formation of Luminescent Crystals of a Single Cation, [(C6H11NC)2Au]+
Noncoordinating anions, which generally play a subordinate role in coordination chemistry, alter the structure, the luminescence, as well as the thermochromic and vapochromic behaviors of salts of the two-coordinate cation, [(C6H11NC)2Au]+.
What IS Inorganic Chemistry?
You might think it straightforward to know what science belongs in a journal that has been around for as long as Inorganic Chemistry (57 years). However, chemistry is becoming more multidisciplinary, the number of submitted papers continues to rise, and journals are proliferating. As a result, authors, reviewers, and, yes, we editors struggle with deciding which papers belong where.
2018 Patient Guide to Cancer Support Services
2018 Patient Guide to Cancer Support Services The Second Annual Patient Guide to Cancer Support Services is provided to you by CONQUER magazine to help you and your loved ones become aware of the many financial support services that may help you receive the best treatment you need and relieve you of the associated financial worries. Included in this guide are financial assistance resources for more than 20 cancer types.
Silver(I)-Mediated Modification, Dimerization, and Polymerization of an Open-Cage Fullerene
The reactions of the open-cage fullerene, MMK-9, with an open 12-membered ring on its surface and silver(I) salts have been examined. The structure of MMK-9 itself has been determined by single-crystal X-ray diffraction. MMK-9 reacts with silver trifluoroacetate in air to form the dimer, {MMK-9(OCH ) Ag(AgO CCF )} . Remarkably, five MeO groups have added to the surface of the open cage in a pattern that surrounds a pentagon immediately adjacent to the opening in the cage.
New health care decision tools should be tailored to needs of the individual Patient - The Chaffee County Times: Opinion
Imagine the flood of questions that follows a cancer diagnosis. How much longer do I have to live? How much am I willing to pay for treatment? What side effects am I willing to bear? These aren’t easy questions. So health care providers and insurance companies are trying to help doctors guide their patients through the process with tools that aid in selecting the best treatment regimens. kAmx? yF?6[ E96 p>6C:42?
Balch: Tailoring health care tools to individual patients
Imagine the flood of questions that follows a cancer diagnosis. How much longer do I have to live? How much am I willing to pay for treatment? What side effects am I willing to bear? These aren't easy questions. So health care providers and insurance companies are trying to help doctors guide their patients through the process with tools that aid in selecting the best treatment regimens.
2015 Is the Year to Put the Patient First | Commentary
President Barack Obama has rightfully been emphasizing the importance of “middle-class economics.” The middle class is the heart of America. But even as the economy picks up as our nation recovers from financial crisis, many hardworking families continue to struggle.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Alan
Contact Alan, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack